Granules India receives USFDA approval for Loratadine Tablets

Granules India has received US Food & Drug Administration (USFDA) approval for Abbreviated New Drug Application filed forLoratadine Tablets USP, 10 mg (OTC). The approved ANDA is the bioequivalent to the Reference Listed Drug (RLD), Claritin Tablets 10 mg by Bayer HealthCare LLC. Granules India intends to commercialise this product shortly.

Powered by Capital Market - Live News